Literature DB >> 11058410

Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice.

G M Sánchez1, L Re, A Giuliani, A J Núñez-Sellés, G P Davison, O S León-Fernández.   

Abstract

We compared the protective abilities of Mangifera indica L. stem bark extract (Vimang) 50-250 mgkg(-1), mangiferin 50 mgkg(-1), vitamin C 100 mgkg(-1), vitamin E 100 mgkg(-1)and beta -carotene 50 mgkg(-1)against the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced oxidative damage in serum, liver, brain as well as in the hyper-production of reactive oxygen species (ROS) by peritoneal macrophages. The treatment of mice with Vimang, vitamin E and mangiferin reduced the TPA-induced production of ROS by the peritoneal macrophages by 70, 17 and 44%, respectively. Similarly, the H(2)O(2)levels were reduced by 55-73, 37 and 40%, respectively, when compared to the control group. The TPA-induced sulfhydryl group loss in liver homogenates was attenuated by all the tested antioxidants. Vimang, mangiferin, vitamin C plus E and beta -carotene decreased TPA-induced DNA fragmentation by 46-52, 35, 42 and 17%, respectively, in hepatic tissues, and by 29-34, 22, 41 and 17%, in brain tissues. Similar results were observed in respect to lipid peroxidation in serum, in hepatic mitochondria and microsomes, and in brain homogenate supernatants. Vimang exhibited a dose-dependent inhibition of TPA-induced biomolecule oxidation and of H(2)O(2)production by peritoneal macrophages. Even if Vimang, as well as other antioxidants, provided significant protection against TPA-induced oxidative damage, the former lead to better protection when compared with the other antioxidants at the used doses. Furthermore, the results indicated that Vimang is bioavailable for some vital target organs, including liver and brain tissues, peritoneal exudate cells and serum. Therefore, we conclude that Vimang could be useful to prevent the production of ROS and the oxidative tissue damages in vivo. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058410     DOI: 10.1006/phrs.2000.0727

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  43 in total

1.  In vivo antimalarial evaluation of MAMA decoction on Plasmodium berghei in mice.

Authors:  Awodayo O Adepiti; Anthony A Elujoba; Oluseye O Bolaji
Journal:  Parasitol Res       Date:  2013-11-22       Impact factor: 2.289

2.  LC-ESI/MS determination of xanthone and secoiridoid glycosides from in vitro regenerated and in vivo Swertia chirayita.

Authors:  Vijay Kumar; Sheela Chandra
Journal:  Physiol Mol Biol Plants       Date:  2014-12-23

3.  Metabolism, pharmacokinetics, and hepatic disposition of xanthones and saponins on Zhimu treatments for exploratively interpreting the discrepancy between the herbal safety and timosaponin A3-induced hepatotoxicity.

Authors:  Yang Xie; Xu Zhou; Hu Pei; Ming-Cang Chen; Zhao-Lin Sun; Ya-Ru Xue; Xiao-Ting Tian; Cheng-Gang Huang
Journal:  Acta Pharmacol Sin       Date:  2018-05-23       Impact factor: 6.150

4.  Anti-inflammatory effects of vicenin-2 and scolymoside in vitro and in vivo.

Authors:  Hyejin Kang; Sae-Kwang Ku; Byeongjin Jung; Jong-Sup Bae
Journal:  Inflamm Res       Date:  2015-12       Impact factor: 4.575

5.  Hepatoprotective effects of vicenin-2 and scolymoside through the modulation of inflammatory pathways.

Authors:  In-Chul Lee; Jong-Sup Bae
Journal:  J Nat Med       Date:  2019-07-26       Impact factor: 2.343

6.  Mangiferin inhibition of proliferation and induction of apoptosis in human prostate cancer cells is correlated with downregulation of B-cell lymphoma-2 and upregulation of microRNA-182.

Authors:  Minglin Li; Huili Ma; Lixin Yang; Peng Li
Journal:  Oncol Lett       Date:  2015-11-16       Impact factor: 2.967

7.  Anti-inflammatory effects of vicenin-2 and scolymoside on polyphosphate-mediated vascular inflammatory responses.

Authors:  In-Chul Lee; Jong-Sup Bae
Journal:  Inflamm Res       Date:  2015-11-30       Impact factor: 4.575

8.  Comparative pharmacokinetic study of mangiferin after oral administration of pure mangiferin and US patented polyherbal formulation to rats.

Authors:  Ananth Kumar Kammalla; Mohan Kumar Ramasamy; Jyothi Inampudi; Govind Prasad Dubey; Aruna Agrawal; Ilango Kaliappan
Journal:  AAPS PharmSciTech       Date:  2014-10-02       Impact factor: 3.246

9.  Comparative analysis of different dietary antioxidants on oxidative stress pathway genes in L6 myotubes under oxidative stress.

Authors:  Purabi Sarkar; Ananya Bhowmick; Sofia Banu
Journal:  Cytotechnology       Date:  2018-03-14       Impact factor: 2.058

10.  Efficacy of mangiferin against Cryptosporidium parvum in a neonatal mouse model.

Authors:  S Perrucci; G Fichi; C Buggiani; G Rossi; G Flamini
Journal:  Parasitol Res       Date:  2006-03-18       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.